The reduction of tumor‐killing GZMK+CD8+ Tem cells and the accumulation of tumor‐resident ZNF683+CD8+ Trm cells indicate substantial remodelling of CD8+ T cell populations in ICB‐resistant RCC, of which the driving factors require in‐depth investigation. The gene discussed is ZNF683; the disease is renal cell adenocarcinoma.